Vitamin D Pilot Study in Patients With Multiple Sclerosis
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 4/21/2016 |
| Start Date: | February 1998 |
| End Date: | June 2000 |
Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.
Inclusion Criteria:
- relapsing remitting MS
Exclusion Criteria:
- MRI contraindicated
We found this trial at
1
site
